Citation Impact
Citing Papers
Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma
2007
Cancer treatment and survivorship statistics, 2022
2022 Standout
Common corruption of the mTOR signaling network in human tumors
2008
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
2009
Guidelines for Identification of, Advocacy for, and Intervention in Neurocognitive Problems in Survivors of Childhood Cancer
2007
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
2010 Standout
Head and neck cancer
2008 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Rapamycin: One Drug, Many Effects
2014 Standout
The Role of Radiotherapy in Oseosarcoma
2009
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
2008 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: Macrophage harbingers of disease severity
2011
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Osteosarcoma
2010 Standout
Molecularly targeted therapy for malignant glioma
2007
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Clinical use of intensity-modulated radiotherapy: part II
2004
Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation
2003
Malignant Gliomas in Adults
2008 Standout
Cancer and Radiation Therapy: Current Advances and Future Directions
2012 Standout
An arc‐sequencing algorithm for intensity modulated arc therapy
2007
Glioblastoma multiforme: State of the art and future therapeutics
2014
Volumetric modulated arc therapy: IMRT in a single gantry arc
2007 Standout
Primary brain tumours in adults
2012 Standout
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
Palliative therapy for osteosarcoma
2011
Radiotherapy: what can be achieved by technical improvements in dose delivery?
2005
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Clinical use of intensity-modulated radiotherapy: part I
2004
Diagnosis and Treatment of High-Grade Astrocytoma
2007
Molecular Predictors in Glioblastoma
2008
Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas
2008
Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments
2013
Cancer treatment and survivorship statistics, 2019
2019 Standout
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
2008
Facile bio-synthesis of gold nanoparticles by using extract of Hibiscus sabdariffa and evaluation of its cytotoxicity against U87 glioblastoma cells under hyperglycemic condition
2015 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
2009
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Works of Shaio Woo being referenced
Initial Clinical Experience with the Peacock Intensity Modulation of a 3-D Conformal Radiation Therapy System
1996
Outpatient Chemotherapy plus Radiotherapy in Sarcomas: Improving Cancer Control with Radiosensitizing Agents
2008
White Matter Lesions Detected by Magnetic Resonance Imaging After Radiotherapy and High-Dose Chemotherapy in Children With Medulloblastoma or Primitive Neuroectodermal Tumor
2004
Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma
2006